| Product Code: ETC6365781 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Belgium continues to rely on key exporters such as the USA, Austria, Netherlands, Hungary, and the UK for its therapeutic vaccines import shipments in 2024. Despite a high concentration level indicated by the Herfindahl-Hirschman Index (HHI), the market is experiencing impressive growth with a compound annual growth rate (CAGR) of 39.8% from 2020 to 2024. However, there was a notable decline in the growth rate from 2023 to 2024 at -59.2%, suggesting potential shifts or challenges in the market dynamics for therapeutic vaccines imports in Belgium.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Therapeutic Vaccines Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Therapeutic Vaccines Market Revenues & Volume, 2022 & 2032F |
3.3 Belgium Therapeutic Vaccines Market - Industry Life Cycle |
3.4 Belgium Therapeutic Vaccines Market - Porter's Five Forces |
3.5 Belgium Therapeutic Vaccines Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Belgium Therapeutic Vaccines Market Revenues & Volume Share, By Therapeutic Vaccines, 2022 & 2032F |
4 Belgium Therapeutic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Belgium |
4.2.3 Rising awareness about preventive healthcare measures in the population |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for vaccine development and approval |
4.3.2 High costs associated with vaccine research, development, and production |
4.3.3 Limited availability of skilled healthcare professionals for administering therapeutic vaccines |
5 Belgium Therapeutic Vaccines Market Trends |
6 Belgium Therapeutic Vaccines Market, By Types |
6.1 Belgium Therapeutic Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Belgium Therapeutic Vaccines Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Belgium Therapeutic Vaccines Market Revenues & Volume, By Peptide Therapeutic Vaccine, 2022 - 2032F |
6.1.4 Belgium Therapeutic Vaccines Market Revenues & Volume, By Cell Therapeutic Vaccine, 2022 - 2032F |
6.1.5 Belgium Therapeutic Vaccines Market Revenues & Volume, By Nucleic Acid Therapeutic Vaccine, 2022 - 2032F |
6.2 Belgium Therapeutic Vaccines Market, By Therapeutic Vaccines |
6.2.1 Overview and Analysis |
6.2.2 Belgium Therapeutic Vaccines Market Revenues & Volume, By Oncotherapy, 2022 - 2032F |
6.2.3 Belgium Therapeutic Vaccines Market Revenues & Volume, By Hepatitis B, 2022 - 2032F |
6.2.4 Belgium Therapeutic Vaccines Market Revenues & Volume, By Tuberculosis, 2022 - 2032F |
6.2.5 Belgium Therapeutic Vaccines Market Revenues & Volume, By Herpes Simplex Virus, 2022 - 2032F |
6.2.6 Belgium Therapeutic Vaccines Market Revenues & Volume, By Others, 2022 - 2032F |
7 Belgium Therapeutic Vaccines Market Import-Export Trade Statistics |
7.1 Belgium Therapeutic Vaccines Market Export to Major Countries |
7.2 Belgium Therapeutic Vaccines Market Imports from Major Countries |
8 Belgium Therapeutic Vaccines Market Key Performance Indicators |
8.1 Number of clinical trials for therapeutic vaccines conducted in Belgium |
8.2 Rate of adoption of therapeutic vaccines in the healthcare system |
8.3 Percentage of healthcare budget allocated to preventive healthcare measures |
8.4 Average time taken for regulatory approval of therapeutic vaccines in Belgium |
8.5 Number of partnerships between pharmaceutical companies and research institutions for vaccine development. |
9 Belgium Therapeutic Vaccines Market - Opportunity Assessment |
9.1 Belgium Therapeutic Vaccines Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Belgium Therapeutic Vaccines Market Opportunity Assessment, By Therapeutic Vaccines, 2022 & 2032F |
10 Belgium Therapeutic Vaccines Market - Competitive Landscape |
10.1 Belgium Therapeutic Vaccines Market Revenue Share, By Companies, 2025 |
10.2 Belgium Therapeutic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here